Technetium TC-99M etarfolatide clinical trials
- studies test it
- 5
- open now
- 0
- in phase 3
- 0
- first study started
- 2000
How each study uses technetium TC-99M etarfolatide is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Name
- Tc 99m EC20
- 5
Studies by the year they started
5 studies that test it; most in 2003 (2)
| Year | Studies |
|---|---|
| 2000 | 1 |
| 2001 | 1 |
| 2002 | 1 |
| 2003 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 5 · Other 0
Related medicines
As reviewed, each with the page that says it.
- One of Radiopharmaceuticals source
Studies
Open first, then newest update. How each study uses technetium TC-99M etarfolatide is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 5
- Safety and Efficacy of FolateScan (Technetium Tc 99m EC20) in Subjects With Suspected Metastatic Renal Cell CarcinomaCompletedPhase 2EndocyteNCT01689662Written as Tc 99m EC20
- Safety and Efficacy of Folatescan (Technetium TC 99M EC20) in Patients With Suspected Ovarian Carcinoma or Recurrent Endometrial CarcinomaCompletedPhase 2EndocyteNCT01689714Written as Tc 99m EC20
- Safety and Biodistribution of Technetium Tc 99m EC20 in Normal Volunteers and Ovarian Cancer PatientsCompletedPhase 1EndocyteNCT01689636Written as Tc 99m EC20
- Safety and Efficacy of FolateScan (Technetium Tc 99m EC20) in Women With Suspected Ovarian or Endometrial CancerCompletedPhase 1EndocyteNCT01686256Written as Tc 99m EC20
- Safety and Efficacy of FalateScan (Technetium Tc 99m EC20) in Patients With Known Suspected Recurrent or Metastatic Cancer From a Solid TumorCompletedPhase 2EndocyteNCT01684098Written as Tc 99m EC20
Codes
What other systems call technetium TC-99M etarfolatide · ClinicalTrials.gg INT018391
- UNII (FDA) WVU7R99FQ6TECHNETIUM TC-99M ETARFOLATIDEOne source FDA
- NCI Thesaurus C152525Technetium Tc-99M EtarfolatideOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | WVU7R99FQ6 | TECHNETIUM TC-99M ETARFOLATIDE | One source FDA |
| NCI Thesaurus | C152525 | Technetium Tc-99M Etarfolatide | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.